Using a routine blood draw for
early cancer detection
Freenome's blood tests look beyond mutations to detect the body's own early-warning signs for cancer, incorporating a multidimensional view of both tumor- and immune-derived signatures that enable the early detection of cancer.
Decoding hidden patterns
By combining deep expertise in molecular biology and advanced computational techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a feedback loop between care and science.